| Page | |
| EDITORIALS |
| 530 | Recommendations from The Medical Education Editor
|
| 533 | Surgical lung biopsy for Idiopathic Pulmonary Fibrosis: Is the risk–benefit ratio changing
|
| 535 | The challenge of interpreting diminished mid-expiratory flow in the presence of normal FEV1 and FVC
|
| 537 | Connecting the dots: Tracing the tuberculosis–diabetes link across time
|
| 539 | Treatable traits—Where we are, where we are headed
Vanessa Marie McDonald BNurs, RN, PhD, Peter Gerard Gibson MBBS, FRACP, DM
10.1111/resp.14758 |
| COMMENTARIES |
| 542 | Protecting children from tobacco industry interference
Matthew Peters MD, FRACP, Moya Vandeleur MB, BCh, BAO, MRCPI, FRACP, PhD
10.1111/resp.14750 |
| 545 | Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest
Stefano Palmucci MD, Linda Reali MD, Gianluca Sambataro MD, Antonio Basile MD, Carlo Vancheri MD, PhD
10.1111/resp.14757 |
| 548 | Global challenges and disparities of care for interstitial lung disease
|
| INVITED REVIEW SERIES |
| Treatable Traits - Personalised Medicine for Life in Airway Disease |
| 551 | Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease
|
| CLINICAL PRACTICE GUIDELINES |
| 563 | World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction
Udit Chaddha, Abhinav Agrawal, Jonathan Kurman, Rosamaria Ortiz-Comino, Herve Dutau, Lutz Freitag, Rocco Trisolini, Christophe Dooms, Lina Zuccatosta, Stefano Gasparini, Felix Herth, Hideo Saka, Pyng Lee, David Fielding, Masahide Oki, Antoni Rosell, Septimiu Murgu
10.1111/resp.14764 |
| INVITED REVIEW |
| 574 | Contemporary Concise Review 2023: Environmental and occupational lung diseases
|
| ORIGINAL ARTICLES |
| Interstitial Lung Disease |
| 588 |
Lung ultrasound is a promising screening tool to rule out interstitial lung disease in patients with rheumatoid arthritis
M Otaola, F Paulin, M Rosemffet, J Balcazar, M Perandones, P Orausclio, T Cazenave, S Rossi, S Marciano, E Schneeberger, G Citera
10.1111/resp.14679
Lung ultrasound is a sensitive diagnostic tool for detecting ILD in RA patients. It is a promising, cost-effective and point-of-care option for ILD screening within this patient population. |
| 596 | Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohort
Veronica Marcoux, Stacey D Lok, Prosanta Mondal, Deborah Assayag, Jolene H Fisher, Shane Shapera, Julie Morisset, Hélène Manganas, Charlene D Fell, Nathan Hambly, P Gerard Cox, Martin Kolb, Andrea S Gershon, Teresa To, Mohsen Sadatsafavi, Nasreen Khalil, Alyson W Wong, Pearce G Wilcox, Christopher J Ryerson, Thao Vu, Kerri A Johannson
10.1111/resp.14695
The diagnostic evaluation for suspected idiopathic pulmonary fibrosis (IPF) may include surgical lung biopsy to obtain histopathology. In our study, we found no evidence of accelerated lung function decline or increased risk of death or lung transplantation in patients with IPF who underwent surgical lung biopsy.
See related editorial |
| Lung Function |
| 605 | Combining small airway parameters with conventional parameters obtained during spirometry to diagnose airflow obstruction: A cross-sectional study
Zhufeng Wang, Junfeng Lin, Lina Liang, Yun Li, Jinhai Huang, Yi Gao, Jinping Zheng
10.1111/resp.14725
In spirometry, it is important to consider both large airway parameters (i.e., forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) and the ratio of FEV1 to FVC (FEV1/FVC)) and small airway parameters (i.e., forced expiratory flow between 25% and 75% of FVC (FEF25%–75%) and forced expiratory flow at 50% and 75% of FVC (FEF50% and FEF75%, respectively) to prevent missing a diagnosis of airflow obstruction.
See related editorial |
| Pulmonary Vascular Disease |
| 614 | Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry
Wanying Xia, Yuling Qian, Yangyi Lin, Ruilin Quan, Yuanhua Yang, Zhenwen Yang, Hongyan Tian, Shengqing Li, Jieyan Shen, Yingqun Ji, Qing Gu, Huijun Han, Changming Xiong, Jianguo He
10.1111/resp.14700
The study demonstrates that off-label use of pulmonary arterial hypertension medication improves long-term survival in patients with chronic thromboembolic pulmonary hypertension. This is a national, multicentre, prospective registry with a large sample size and low rate of loss to follow-up. The efficacy is more transparent after rigorously reducing bias. |
| Tuberculosis |
| 624 | Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis
Kyung Hoon Kim, Hyung Woo Kim, Yong Hyun Kim, Yeonhee Park, Sung Soo Jung, Jin Woo Kim, Jee Youn Oh, Heayon Lee, Sung Kyoung Kim, Sun-Hyung Kim, Jiwon Lyu, Yousang Ko, Sun Jung Kwon, Yun-Jeong Jeong, Do Jin Kim, Hyeon-Kyoung Koo, Yangjin Jegal, Sun Young Kyung, Sung Soon Lee, Jae Seuk Park, Ju Sang Kim, Jinsoo Min
10.1111/resp.14714
The effect of various stages of diabetis mellitus (DM) on the outcomes of patients with tuberculosis (TB) was analysed. Untreated and complicated DM at the time of TB diagnosis increased the risk of unfavourable outcomes.
See related editorial |
| FORUM AND DEBATE |
| Respirology Column |
| 633 | VCD/ILO: Seeing and believing
|
| 635 | Childhood disadvantage—Factoring it in
|
| Letter from Asia-Pacific and Beyond |
| 637 | Letter from Japan
|
| Correspondence |
| 640 | Evaluating artificial intelligence responses to respiratory medicine questions
|
